Literature DB >> 8837677

Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3.

K Kreiss1, M M Mroz, L S Newman, J Martyny, B Zhen.   

Abstract

We examined the prevalence of beryllium sensitization in relation to work process and beryllium exposure measurements in a beryllia ceramics plant that had operated since 1980. We interviewed 136 employees (97.8% of the workforce), ascertained beryllium sensitization with the beryllium lymphocyte proliferation blood test, and reviewed historical industrial hygiene measurements. Of eight beryllium-sensitized employees (5.9%), six (4.4% of participating employees) had granulomatous disease on transbronchial lung biopsy. Machinists had a sensitization rate of 14.3% compared to a rate of 1.2% among other employees. Machining had significantly higher general area and breathing zone measurements than did other processes in the time period in which most beryllium-sensitized cases had started machining work. Daily weighted average (DWA) estimates of exposure for matching processes also exceeded estimates for other work processes in that time period, with a median DWA of 0.9 microgram/m3. Machining process DWAs accounted for the majority of DWAs exceeding the 2.0 micrograms/m3 OSHA standard, with 8.1% of machining DWAs above the standard. We conclude that lowering machining process-related exposures may be important to lowering risk of beryllium disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8837677     DOI: 10.1002/(SICI)1097-0274(199607)30:1<16::AID-AJIM3>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  35 in total

Review 1.  Clinical application of beryllium lymphocyte proliferation testing.

Authors:  Barbara P Barna; Daniel A Culver; Belinda Yen-Lieberman; Raed A Dweik; Mary Jane Thomassen
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

2.  Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant.

Authors:  K Kreiss; M M Mroz; B Zhen; H Wiedemann; B Barna
Journal:  Occup Environ Med       Date:  1997-08       Impact factor: 4.402

3.  Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers.

Authors:  Kristin J Cummings; David C Deubner; Gregory A Day; Paul K Henneberger; Margaret M Kitt; Michael S Kent; Kathleen Kreiss; Christine R Schuler
Journal:  Occup Environ Med       Date:  2006-10-16       Impact factor: 4.402

4.  Beryllium's public relations problem: protecting workers when there is no safe exposure level.

Authors:  David Michaels; Celeste Monforton
Journal:  Public Health Rep       Date:  2008 Jan-Feb       Impact factor: 2.792

5.  Crystal structure of HLA-DP2 and implications for chronic beryllium disease.

Authors:  Shaodong Dai; Guinevere A Murphy; Frances Crawford; Douglas G Mack; Michael T Falta; Philippa Marrack; John W Kappler; Andrew P Fontenot
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-31       Impact factor: 11.205

6.  Efficacy of a program to prevent beryllium sensitization among new employees at a copper-beryllium alloy processing facility.

Authors:  Carrie A Thomas; Rachel L Bailey; Michael S Kent; David C Deubner; Kathleen Kreiss; Christine R Schuler
Journal:  Public Health Rep       Date:  2009 Jul-Aug       Impact factor: 2.792

7.  Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.

Authors:  Douglas G Mack; Allison M Lanham; Michael T Falta; Brent E Palmer; Lisa A Maier; Andrew P Fontenot
Journal:  Am J Respir Crit Care Med       Date:  2010-03-18       Impact factor: 21.405

8.  Progression from beryllium exposure to chronic beryllium disease: an analytic model.

Authors:  Philip Harber; Siddharth Bansal; John Balmes
Journal:  Environ Health Perspect       Date:  2009-02-27       Impact factor: 9.031

9.  Beryllium-specific CD4+ T cells in blood as a biomarker of disease progression.

Authors:  Allison K Martin; Douglas G Mack; Michael T Falta; Margaret M Mroz; Lee S Newman; Lisa A Maier; Andrew P Fontenot
Journal:  J Allergy Clin Immunol       Date:  2011-09-23       Impact factor: 10.793

10.  Low prevalence of chronic beryllium disease among workers at a nuclear weapons research and development facility.

Authors:  Mehrdad Arjomandi; James Seward; Michael B Gotway; Stephen Nishimura; George P Fulton; Josef Thundiyil; Talmadge E King; Philip Harber; John R Balmes
Journal:  J Occup Environ Med       Date:  2010-06       Impact factor: 2.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.